TIFFANY SMITH: Open Payments
NPI 1609507482 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 71 payments from 21 companies in 2025. Trend: 2023 $793 · 2024 $1,014 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $158 |
| ABBVIE INC. | 16 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $87 |
| Lilly USA, LLC | 5 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Corcept Therapeutics | 3 | $59 |
| Novo Nordisk Inc | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 3 | $44 |
Products named: NURTEC ODT, Kerendia, CAPLYTA, MOUNJARO, JARDIANCE, VRAYLAR, Korlym, QULIPTA.
Industry payments across KY — which companies pay providers there.
